Porsha sells AEGR 30.69: Aegerion Pharmaceuticals Receives New Coverage from Analysts at Goldman Sachs (AEGR)
Investment analysts at Goldman Sachs assumed coverage on shares of Aegerion Pharmaceuticals (NASDAQ:AEGR) in a note issued to investors on Tuesday, TheFlyOnTheWall.com reports. The firm set a âsellâ rating and a $27.00 price target on the stock. ...
48 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home